Asthma epidemiology, pathophysiology, and initial evaluation

Pediatrics in Review

Volumn 30, Issue 9, 2009, Pages 331-336

  Hill, Vanessa L ^a   Wood, Pamela Runge ^b  

^a Department of Pediatrics ^*

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID;

ANTIINFLAMMATORY ACTIVITY; ASTHMA; ATOPY; BRONCHOSPASM; DIFFERENTIAL DIAGNOSIS; FORCED EXPIRATORY VOLUME; HEALTH DISPARITY; HUMAN; INFLAMMATION; LUNG FUNCTION; MORTALITY; PATHOPHYSIOLOGY; PREVALENCE; REVIEW; RISK ASSESSMENT; SPIROMETRY; WHEEZING; ARTICLE; CHILD; COST OF ILLNESS; COUGHING; RISK FACTOR; UNITED STATES; VOCAL CORD;

ASTHMA; CHILD; COST OF ILLNESS; COUGH; DIAGNOSIS, DIFFERENTIAL; FORCED EXPIRATORY VOLUME; HUMANS; PREVALENCE; RISK FACTORS; UNITED STATES; VOCAL CORDS;

EID: 74049100847     PISSN: 01919601     EISSN: 15263347     Source Type: Journal    
DOI: 10.1542/pir.30-9-331     Document Type: Review

References (8)

1. National Asthma Education and Prevention Program. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. Full Report 2007. NIH Publication 07-4051. Bethesda, Md: National Heart, Lung, and Blood Institute; 2007. Available at: http://www.nhlbi.nih.gov/guidelines/asthma/. Accessed June 2009
2. Bloom B, Cohen RA. Summary health statistics for U.S. children: National Health Interview Survey, 2007. National Center for Health Statistics. Vital Health Stat. 2009;10(239). Available at: www.cdc.gov/nchs/nhis.htm. Accessed June 2009
3. Akinbami LJ. The state of childhood asthma, United States, 1980-2005. Advance Data from Vital and Health Statistics; No 381. Hyattsville, Md: National Center for Health Statistics; 2006. Available at: http://www.cdc.gov/ nchs/data/ad/ad381.pdf. Accessed June 2009
4. Taussig LM, Wright AL, Holberg CJ, Halonen M, Morgan WJ, Martinez FD. Tucson Children's Respiratory Study: 1980 to present. J Allergy Clin Immunol. 2003;111:661-675
5. Phelan PD, Robertson CF, Olinsky A. The Melbourne Asthma Study: 1964-1999. J Allergy Clin Immunol. 2001;109:189-194
6. Strunk RC. The fatality-prone asthmatic child and adolescent. Immunol Allergy Clin North Am. 1998;18:85-97
7. McDaniel M, Paxson C, Waldfogel J. Racial disparities in childhood asthma in the United States: evidence from the National Health Interview Survey, 1997 to 2003. Pediatrics. 2006;117: e868-e877
8. Busse W, Corren J, Lanier BQ, et al. Omalizumab, anti-IgE recombinant humanized monoclonal antibody for the treatment of severe allergic asthma. J Allergy Clin Immunol. 2001;108: 184-190